Fig. 5
From: Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia
Kaplan-Meier curve for the impact of SOX2 expression and OCT3/4 expression on OS and DFS of ALL patients. A, B Patients with low SOX2 expression (< 16.3%) and low OCT3/4 expression (< 1.55%) had longer cumulative OS survival as compared to those with high expression (P = 0.007, and P = 0.016 respectively). C, D Patients with low SOX2 expression (< 16.3%) had longer cumulative DFS as compared to those with high expression (P = 0.006). While DFS was not significantly different between those with high and low OCT3/4 (P = 0.284)